# Nordic Study in Cardiac and Lung Transplantation: Outcome in Relation to Cyclosporine Microemulsion C2 Levels

> **NCT00154193** · PHASE4 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 190 (actual)

## Conditions studied

- Heart and Lung Transplant

## Interventions

- **DRUG:** cyclosporine

## Key facts

- **NCT ID:** NCT00154193
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2007-11
- **Final completion:** —
- **Target enrollment:** 190 (ACTUAL)
- **Last updated:** 2020-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00154193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00154193, "Nordic Study in Cardiac and Lung Transplantation: Outcome in Relation to Cyclosporine Microemulsion C2 Levels". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00154193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*